A Nomogram to Predict Distant Metastases After Multimodality Therapy for Patients With Localized Esophageal Cancer.

Autor: Sudo K; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, Wang X; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, Xiao L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, Wadhwa R; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, Shiozaki H; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, Elimova E; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, Rice DC; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, Lee JH; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, Weston B; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, Bhutani MS; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, Hiremath A; Department of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, Charalampakis N; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, Komaki R; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, Blum MA; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, Swisher SG; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, Maru DM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, Skinner HD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, Garris JL; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, Rogers JE; Department of The University of Pharmacy Clinical Programs, Texas MD Anderson Cancer Center, Houston, Texas, Hofstetter WL; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, Ajani JA; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Publikováno v: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2016 Feb; Vol. 14 (2), pp. 173-9.

Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical Implications.

Autor: Neishaboori N; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Tex., USA., Wadhwa R, Nogueras-González GM, Elimova E, Shiozaki H, Sudo K, Charalampakis N, Hiremath A, Lee JH, Bhutani MS, Weston B, Blum MA, Rogers JE, Garris JL, Rice DC, Komaki R, Swisher SG, Skinner HD, Hofstetter WL, Ajani JA

Publikováno v: Oncology [Oncology] 2015; Vol. 89 (2), pp. 65-9. Date of Electronic Publication: 2015 Mar 05.

Improving the success rate of gluteal intramuscular injections.

Autor: Boyd AE; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., DeFord LL, Mares JE, Leary CC, Garris JL, Dagohoy CG, Boving VG, Brook JP, Phan A, Yao JC

Publikováno v: Pancreas [Pancreas] 2013 Jul; Vol. 42 (5), pp. 878-82.